AngioJet® (MEDRAD ... and simultaneously evacuates the thrombotic material from the vessel Rescueâ„¢ (Boston Scientific, MA, USA) 4.5 F aspiration catheter advanced over a guidewire through ...
She had been treated 8 years prior for a right popliteal artery occlusion via overnight CDT with Ekos infusion catheter (Boston Scientific Corporation) followed by rheolytic thrombectomy with AngioJet ...
Stifel raised the firm’s price target on Boston Scientific (BSX) to $120 from $115 and keeps a Buy rating on the shares after having hosted ...
Boston Scientific (NYSE:BSX – Get Free Report) had its price objective lifted by equities research analysts at Raymond James ...
Barclays raised the firm’s price target on Boston Scientific (BSX) to $118 from $111 and keeps an Overweight rating on the shares. The firm ...
In addition, technological advancements such as the increasing use of AI, predictive analysis, and advanced algorithms are ...
After the National Institutes of Health issued an order Friday night that would dramatically reduce funding, professor ...
Stifel analysts increased their price target on Boston Scientific Corporation (NYSE:BSX) shares from $115.00 to $120.00, while reiterating a Buy rating for the medical device company. The adjustment ...
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is Boston Scientific (BSX) one of those stocks right now? A quick glance at the ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
His next chance to suit up will come Wednesday against San Antonio, which is Boston's final contest before the All-Star break. Tatum is questionable for Monday's game against the Heat due to right ...
Tillman was not on Boston's initial injury report, so this is apparently a new issue for the forward. Tillman has played just six minutes in one February appearance, however, so this news won't ...